Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001185185-24-000145
Filing Date
2024-02-08
Accepted
2024-02-08 15:36:35
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A amgreat20230930_10qa.htm   iXBRL 10-Q/A 781224
2 EXHIBIT 31.1 ex_623684.htm EX-31.1 9145
3 EXHIBIT 31.2 ex_623915.htm EX-31.2 11702
4 EXHIBIT 32.1 ex_623685.htm EX-32.1 5570
5 EXHIBIT 32.2 ex_623916.htm EX-32.2 4359
  Complete submission text file 0001185185-24-000145.txt   5038154

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aagh-20230930.xsd EX-101.SCH 52526
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aagh-20230930_cal.xml EX-101.CAL 35961
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aagh-20230930_def.xml EX-101.DEF 238306
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aagh-20230930_lab.xml EX-101.LAB 421070
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aagh-20230930_pre.xml EX-101.PRE 247554
68 EXTRACTED XBRL INSTANCE DOCUMENT amgreat20230930_10qa_htm.xml XML 564305
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-27873 | Film No.: 24608747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)